GO
Loading...

Pfizer Prevails in Patent Suit Against Teva

Pfizer said on Tuesday that a U.S. federal court upheld the three main patents covering its Celebrex painkiller, winning a challenge by generic drugmaker Teva Pharmaceutical Industries.

The decision bars Teva from launching a competitor drug in the U.S. until December 2015, Pfizer said.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

  • Private Jet

    Like migrating birds, private jet setters follow a basic instinct when it comes to their flight paths: They follow better weather.

  • Fake Apple Watches... can you tell the difference?

    CNBC's Eunice Yoon reports Apple Watch is officially available today but already fake watches are hitting the streets.

  • Alphorn players perform in Nendaz, Switzerland.

    Switzerland is the happiest place on Earth, thanks to its high performing GDP and healthy life expectancy rates of its citizens.

U.S. Video